ask="0.90"
ask_size="2000"
average_daily_volume="532145"
bid="0.20"
bid_size="500"
book_value="1.64"
change="+0.01"
change_from_200_day_moving_average="-0.44"
change_from_50_day_moving_average="-0.09"
change_from_52_week_high="-2.81"
change_From_52_week_low="0.04"
change_in_percent="+1.77%"
close="0.57"
dividend_pay_date="8/19/2015"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-1.59"
ebitda="-16.45M"
eps_estimate_current_year="-1.52"
eps_estimate_next_quarter="-0.41"
eps_estimate_next_year="-1.24"
ex_dividend_date="8/20/2015"
float_shares="5356000"
high="0.60"
high_52_weeks="3.38"
last_trade_date="1/26/2017"
last_trade_price="0.57"
last_trade_size="331"
last_trade_time="4:00pm"
low="0.55"
low_52_weeks="0.53"
market_capitalization="6.85M"
moving_average_200_day="1.01"
moving_average_50_day="0.66"
name="Catalyst Biosciences
Inc."
notes="N/A"
one_year_target_price="3.25"
open="0.57"
pe_ratio="N/A"
peg_ratio="0.02"
percent_change_from_200_day_moving_average="-43.34%"
percent_change_from_50_day_moving_average="-13.79%"
percent_change_from_52_week_high="-83.14%"
percent_change_from_52_week_low="+7.49%"
previous_close="0.56"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.34"
price_per_sales="15.41"
revenue="437000.00"
shares_outstanding="12026000"
short_ratio="0.12"
stock_exchange="NCM"
symbol="CBIO"
volume="79905"
weeks_range_52="0.53 - 3.38"
